论文部分内容阅读
目的 :为了评价复发性肝细胞癌的非手术治疗方法的疗效。方法 :采用经皮肝动脉化疗栓塞(TAE)结合B超引导下无水酒精注射(PEI)双介入治疗56例复发性肝细胞癌 ,并以同期TAE治疗的42例复发性肝癌及28例手术再切除的复发性肝癌为对照。结果 :TAE +PEI组的1 ,3 ,5年累计生存率分别为89 0 % ,66 5 %和33 8 % ,其中单个病灶者1 ,3 ,5年生存率为91 3 % ,79 6 %和46 9 %。结论 :TAE +PEI治疗复发性肝癌的疗效明显优于单独TAE治疗。对单个病灶复发的病人 ,TAE +PEI治疗的疗效接近于再次手术切除者 ;对多个病灶复发 ,疗效也较为理想 ,可作为不能手术切除的复发性肝癌的首选疗法。
Objective: To evaluate the efficacy of non-surgical treatment of recurrent hepatocellular carcinoma. Methods: Percutaneous transhepatic arterial chemoembolization (TAE) combined with percutaneous ethanol injection (PEI) double interventional treatment of 56 cases of recurrent hepatocellular carcinoma and 42 cases of recurrent hepatocellular carcinoma treated with TAE in the same period and 28 cases of surgery Resection of recurrent liver cancer as a control. Results The 1, 3, 5-year cumulative survival rates of TAE + PEI group were 89.0%, 66.5% and 33.8%, respectively. The 1-, 3-, 5- year survival rates of single lesions were 91.3% and 79.6% And 46 9%. Conclusion: The efficacy of TAE + PEI in the treatment of recurrent hepatocellular carcinoma is better than that of TAE alone. For patients with recurrent lesions, the efficacy of TAE + PEI treatment is similar to those of resection resection; for multiple lesions, the curative effect is also ideal, which can be used as the first choice for unresectable recurrent HCC.